Pancreatic proglucagon gene expression is promoted upon fasting and hypoglycaemia induction and inhibited by insulin
GLP-1 receptors are expressed in the heart muscle cells, immune system cells in the heart, and in the lining of blood vessels.[ref] GLP-1 RAs have been shown to help in heart failure and also to have beneficial effects on heart rhythm.[ref] Related article : Cardiovascular disease genetic risk factors Cancer Research: Retatrutide, a GLP-1/GIP/GCG triple agonist, has recently been shown to reduce pancreatic tumor mass in animals
It has several functions, including enhancing insulin secretion, reducing glucagon production, and slowing gastric emptying, which all synergistically work to reduce blood glucose levels
GLP-1 medications are capable of changing the way the digestive system works
In the study, participants with a responsive genetic score had an 82% increase in the likelihood of acheiving weight loss with a GLP-1 medication.[ref] Another study showed that GLP1 receptor variants are associated with greater weight loss on GLP-1 RA drugs.[ref] Common genetic variants in the GLP1R (GLP-1 receptor) gene impact weight and type 2 diabetes risk
Members get access to: Clinicians trained in obesity medicine, self-paced lifestyle change program designed by doctors, psychologists, and behavioral scientists & our exclusive in-app community
